Novo's NovoRapid Has 10-20 Min. Onset Of Action - EU Labeling
Executive Summary
Novo Nordisk's diabetes mellitus treatment insulin aspart has an onset of action time of 10 to 20 minutes, according to European draft labeling for the human insulin analogue.